The 36-month beta value for STRM is at 1.64. Analysts have varying views on the stock, with 1 analysts rating it as a “buy,” 0 rating it as “overweight,” 2 as “hold,” and 0 as “sell.”
The public float for STRM is 51.60M, and currently, shorts hold a 0.07% of that float. The average trading volume for STRM on September 23, 2024 was 140.41K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
STRM) stock’s latest price update
The stock of Streamline Health Solutions, Inc (NASDAQ: STRM) has decreased by -14.52 when compared to last closing price of 0.20.Despite this, the company has seen a loss of -22.83% in its stock price over the last five trading days. seekingalpha.com reported 2024-09-12 that Streamline Health Solutions, Inc. (NASDAQ:STRM ) Q2 2024 Earnings Conference Call September 12, 2024 9:00 AM ET Company Participants Jacob Goldberger – Vice President, Finance Ben Stilwill – President & Chief Executive Officer B.J. Reeves – Chief Financial Officer Conference Call Participants Matt Hewitt – Craig-Hallum Michael Potter – Monarch Capital Operator Greetings.
STRM’s Market Performance
Streamline Health Solutions, Inc (STRM) has seen a -22.83% fall in stock performance for the week, with a -71.36% decline in the past month and a -65.69% plunge in the past quarter. The volatility ratio for the week is 21.29%, and the volatility levels for the past 30 days are at 20.39% for STRM. The simple moving average for the past 20 days is -59.95% for STRM’s stock, with a -60.94% simple moving average for the past 200 days.
Analysts’ Opinion of STRM
Many brokerage firms have already submitted their reports for STRM stocks, with Lake Street repeating the rating for STRM by listing it as a “Buy.” The predicted price for STRM in the upcoming period, according to Lake Street is $3 based on the research report published on November 21, 2022 of the previous year 2022.
Hilliard Lyons gave a rating of “Buy” to STRM, setting the target price at $6.50 in the report published on April 04th of the previous year.
STRM Trading at -63.46% from the 50-Day Moving Average
After a stumble in the market that brought STRM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -83.10% of loss for the given period.
Volatility was left at 20.39%, however, over the last 30 days, the volatility rate increased by 21.29%, as shares sank -70.86% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -65.79% lower at present.
During the last 5 trading sessions, STRM fell by -22.83%, which changed the moving average for the period of 200-days by -40.70% in comparison to the 20-day moving average, which settled at $0.4014. In addition, Streamline Health Solutions, Inc saw -60.24% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for STRM
Current profitability levels for the company are sitting at:
- -0.87 for the present operating margin
- 0.52 for the gross margin
The net margin for Streamline Health Solutions, Inc stands at -0.93. The total capital return value is set at -0.67. Equity return is now at value -80.09, with -40.77 for asset returns.
Based on Streamline Health Solutions, Inc (STRM), the company’s capital structure generated 0.44 points at debt to capital in total, while cash flow to debt ratio is standing at -0.17. The debt to equity ratio resting at 0.78. The interest coverage ratio of the stock is -11.7.
Currently, EBITDA for the company is -3.26 million with net debt to EBITDA at -3.56. When we switch over and look at the enterprise to sales, we see a ratio of 0.97. The receivables turnover for the company is 5.82for trailing twelve months and the total asset turnover is 0.52. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.61.
Conclusion
In conclusion, Streamline Health Solutions, Inc (STRM) has had a bad performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
